Skip to content

Sanofi

Follow

13F filer, CIK 1121404, Paris, France

Sanofi reported $629,867,590 across 16 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-05. Its ten largest share positions make up 92.09% of the portfolio.

Accepted , ingested 13F-HR 0001193125-26-448717

Period
2026-09-30
Reported value
$630M
Holdings
16
Top 10 weight
92.09%
New
6
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KRSAnew+1,994,011$63.8M
ETRAnew+2,461,948$27.7M
ATTOnew+1,082,855$18.6M
LTGOnew+672,778$11.2M
SCTXnew+500,000$9.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ODTXreduced-1,718-$38.2K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001193125-26-448717, largest first. % of portfolio is the value over $629,867,590, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,197,737 shares; 2025Q1: 12,197,737 shares; 2025Q2: 12,197,737 shares; 2025Q3: 12,197,737 shares; 2025Q4: 12,197,737 shares; 2026Q1: 12,197,737 shares; 2026Q2: 12,197,737 shares; 2026Q3: 12,197,737 shares 12,197,737$134M21.3%0Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,157,926 shares; 2025Q1: 1,157,926 shares; 2025Q2: 1,157,926 shares; 2025Q3: 1,157,926 shares; 2025Q4: 1,157,926 shares; 2026Q1: 1,157,926 shares; 2026Q2: 1,157,926 shares; 2026Q3: 1,157,926 shares 1,157,926$116M18.4%0Timeline
NVAXNOVAVAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,880,481 shares; 2025Q1: 6,880,481 shares; 2025Q2: 6,880,481 shares; 2025Q3: 6,880,481 shares; 2025Q4: 6,880,481 shares; 2026Q1: 6,880,481 shares; 2026Q2: 6,880,481 shares; 2026Q3: 6,880,481 shares 6,880,481$74.4M11.81%0Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,994,011 shares 1,994,011$63.8M10.13%newTimeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,991,918 shares; 2026Q3: 1,990,200 shares 1,990,200$44.2M7.02%-1,718Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 821,917 shares; 2025Q1: 821,917 shares; 2025Q2: 821,917 shares; 2025Q3: 821,917 shares; 2025Q4: 821,917 shares; 2026Q1: 821,917 shares; 2026Q2: 821,917 shares; 2026Q3: 821,917 shares 821,917$41.3M6.56%0Timeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,783,096 shares; 2026Q2: 2,783,096 shares; 2026Q3: 2,783,096 shares 2,783,096$30.9M4.9%0Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 821,917 shares; 2026Q3: 821,917 shares 821,917$29.1M4.62%0Timeline
ETRAELECTRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,461,948 shares 2,461,948$27.7M4.4%newTimeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,082,855 shares 1,082,855$18.6M2.95%newTimeline
LTGOLATIGO BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 672,778 shares 672,778$11.2M1.78%newTimeline
IMRXIMMUNEERING CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,708,559 shares; 2025Q4: 2,708,559 shares; 2026Q1: 2,708,559 shares; 2026Q2: 2,708,559 shares; 2026Q3: 2,708,559 shares 2,708,559$11.1M1.76%0Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 912,041 shares; 2026Q1: 912,041 shares; 2026Q2: 912,041 shares; 2026Q3: 912,041 shares 912,041$9.29M1.48%0Timeline
SCTXSCRIBE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000$9.2M1.46%newTimeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,198,500 shares 2,198,500$6.97M1.11%newTimeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 244,083 shares; 2025Q1: 244,083 shares; 2025Q2: 244,083 shares; 2025Q3: 244,083 shares; 2025Q4: 244,083 shares; 2026Q1: 244,083 shares; 2026Q2: 244,083 shares; 2026Q3: 244,083 shares 244,083$2.02M0.32%0Timeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-448717 base2026-11-05

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001193125-26-448717 Quarter ended 2026-09-302026-11-05
13F-HR 0001193125-26-318812 Quarter ended 2026-06-302026-07-28acceptance time not in the bulk data set
13F-HR 0001193125-26-210525 Quarter ended 2026-03-312026-05-07acceptance time not in the bulk data set
13F-HR 0001193125-26-045633 Quarter ended 2025-12-312026-02-11acceptance time not in the bulk data set
13F-HR 0001193125-25-263831 Quarter ended 2025-09-302025-11-04acceptance time not in the bulk data set
13F-HR 0000950123-25-006717 Quarter ended 2025-06-302025-07-29acceptance time not in the bulk data set
13F-HR 0000950123-25-004066 Quarter ended 2025-03-312025-05-06acceptance time not in the bulk data set
13F-HR 0000950123-25-002465 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set